43 new COVID-19 cases reported in Quad County area Friday


  • Discuss Comment, Blog about
  • Print Friendly and PDF
Carson City Health and Human Services reported 43 new cases and 197 additional recoveries of COVID-19 in the Quad-County Region on Friday.
This brings the total number of cases to 10,879, with 7,591 recoveries and 192 deaths; 3,096 cases remain active.

Total Cases 

Active Cases

Recoveries

Deaths

*Population

Carson City

5,747

1,624

4,017

106

56,546

Douglas County

2,416

691

1,696

29

49,695

Lyon County

2,642

765

1,822

55

57,987

Storey County

74

16

56

2

4,465

Quad-County

10,879

3,096

7,591

192

168,693

*Population information taken from the Nevada Health Response Dashboard found at https://nvhealthresponse.nv.gov/


CCHHS COVID-19 Vaccinations
Vaccine statistics are updated weekly on Tuesday. These are the doses received and administered by CCHHS ONLY. This does not include other vaccinations by other entities in the Quad-County Region. As of February 1, 2021

Total Number of Doses received: 8,775

1st Doses: 7,475

2nd Doses: 1,300

Total Number of Doses administered: 8,704

1st Doses: 7,613

2nd Doses: 1,091

 
Drive-Thru COVID-19 Testing for Quad-County Residents 
Testing is for Quad-County (Carson City, Douglas, Lyon, and Storey County) residents ONLY, all others will be turned away. Events may be canceled 48 hours in advance if inclement weather is expected. Testing is free of charge, no appointments or reservations. To view all upcoming events visit https://gethealthycarsoncity.org/events/.

Date

Time

Location

2/10/2021

1 p.m. to 3 p.m.

Storey County Emergency Management Satellite Office

20 E. Street, Virginia City

2/12/2021

9 a.m. to 11 a.m.

Carson City Corporate Yard

549 Airport Rd.

For those who are experiencing symptoms of COVID-19 or have questions, call the Quad-County COVID-19 Hotline Monday through Friday, 8:30 am to 4:30 pm. Spanish speakers are available. The phone number is (775) 434-1988.

Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment